Here is what the delegates said about the event:
“I thought it was an excellent event, with a quality turnout, a relevant and accomplished crowd. It was of optimal size, large enough to have critical mass and justify the travel to Hong Kong, small enough to get to know many of the attendees and understand their business better than would otherwise be the case.”
Nicholas C. Ashby, Chief Executive Officer, CELADON CAPITAL
“From it’s first edition, Asia Biotech Invest is already the "must-go" event for both biotech investors and fund-seekers in Asia.”
Andrew Badrot, Partner and Chief Executive Officer, CMS ADVISORS
“Asia Biotech conference offers a unique venue for all life science stakeholders – entrepreneurs, large pharma and biotech, and investors – to discuss the latest trends and opportunities for life science investing in Asia and cultivates in-depth discussion across a wide range of topics from regulatory to partnerships to raising capital.”
Victor E. Tong Jr., Principal, Decheng Capital
“I thought the symposium was well organized and a real success. I learned a great deal!”
Dr. Michael A. Berry, Managing Director, DISCOVERY INVESTING
“I was very pleased to have been involved with the Asia Biotech Invest event, which
I thought was very worthwhile and extremely well organised.”
Mark Roberts, Partner,
DAVIES COLLINSON CAVE
"Dynamic platform of Biotech advocates sharing intelligence, challenges, and inspirations."
Cecilia Chan, Assistant Trade Commissioner, UK TRADE & INVESTMENT
"Great connections made with an excellent program as a bonus."
David Anderson, Deputy Director, BURNET INSTITUTE
"Fantastic mix of speaker/topics."
Kevin Leung, Analyst, ELLIS BRADY MANAGEMENT
"Excellent platform for investors and biotech companies."
Ng Swee Choong, R&D Engineer, COOK ASIA